Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions to Share COVID-19 Experience with Leading Government Commission
EDEN PRAIRIE, Minn. , Sept. 23, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload conditions, today announced it will be providing testimony to the U.S.
View HTML
Toggle Summary CHF Solutions to Participate at Lake Street Capital Markets’ 4th Annual BIG4 Conference on September 17, 2020
EDEN PRAIRIE, Minn. , Sept. 11, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will participate in Lake Street Capital Markets’ 4 th Annual Best Ideas Growth
View HTML
Toggle Summary CHF Solutions’ Physician-Led Webinar Concludes Fluid Overloaded Heart Failure Patients Benefit from Ultrafiltration
EDEN PRAIRIE, Minn. , Sept. 10, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced key takeaways from a recent webinar, where Dr. John L.
View HTML
Toggle Summary CHF Solutions Continues Physician-Led Webinar Series Discussing Precise Management of Fluid Overload in Patients with Acute Heart Failure
EDEN PRAIRIE, Minn. , Sept. 03, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will host an interactive, physician-led webinar to discuss “Precision Medicine for
View HTML
Toggle Summary CHF Solutions Receives 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement
EDEN PRAIRIE, Minn. , Sept. 01, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced today receipt of written notification from the Nasdaq Stock Market that it has granted the company’s
View HTML
Toggle Summary CHF Solutions Applauds U.S Congress Request to U.S. International Trade Commission to Identify Products to Treat COVID-19
EDEN PRAIRIE, Minn. , Aug. 27, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today commended a request from the U.S. Congress to the U.S. International Trade Commission (USITC) concerning
View HTML
Toggle Summary CHF Solutions, Inc. Announces Closing of $14.37 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
EDEN PRAIRIE, Minn. , Aug. 21, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) today announced the closing of an underwritten public offering of units for gross proceeds of approximately $14.37 million , which includes the full exercise of the underwriter's over-allotment option to
View HTML
Toggle Summary CHF Solutions, Inc. Announces Pricing of $12.5 Million Underwritten Public Offering
EDEN PRAIRIE, Minn. , Aug. 19, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced the pricing of an underwritten public offering of units for gross proceeds of approximately
View HTML
Toggle Summary CHF Solutions’ Aquadex Products Granted Federal Supply Schedule Contract
EDEN PRAIRIE, Minn. , Aug. 18, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced that its Aquadex™ product line has been added to the Federal Supply Schedule, expanding access
View HTML
Toggle Summary CHF Solutions, Inc. Announces 14 Percent Increase in Revenue for Second Quarter 2020 Over Previous Quarter and Provides Company Update
EDEN PRAIRIE, Minn. , Aug. 04, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the second quarter ended June 30, 2020 , which included the following highlights: Revenue for the second quarter ended June 30, 2020 , was $1.9 million , an increase of 14
View HTML